Neurocrine Biosciences (NBIX) Amortizatization of Intangibles (2010 - 2026)

Neurocrine Biosciences has reported Amortizatization of Intangibles for 17 years, with the latest figure at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles rose 30.0% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (down 83.27% YoY), and the FY2025 full-year result was $4.1 million, down 84.35% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $1.3 million, up from -$6.6 million in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $23.5 million in Q4 2024, with the low at -$11.4 million in Q3 2024.
• Historically, Amortizatization of Intangibles has averaged $2.2 million across 5 years, with a median of $1.0 million in 2025.
• The largest YoY upside for Amortizatization of Intangibles was 376.47% in 2024 against a maximum downside of 290.0% in 2024.
• Neurocrine Biosciences' Amortizatization of Intangibles stood at -$3.7 million in 2022, then slumped by 129.73% to -$8.5 million in 2023, then jumped by 376.47% to $23.5 million in 2024, then sank by 128.09% to -$6.6 million in 2025, then soared by 119.7% to $1.3 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $1.3 million (Q1 2026), -$6.6 million (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.